Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
-
-
TechCrunch Disrupt 2026’s Real World AI Stage features robots, automated factories, and extinct animals
On our new Real World AI stage, we’ll be focusing on the intersection between the digital and physical, and all the ways we’ll continue to see a blending of the two.
